SPRINT Trial Risk Stratification Calculator
Patient profile and treatment target
Review selected characteristics used in the SPRINT trial and compare the trial's two systolic blood-pressure targets.
Enter patient details
Complete age, kidney function category, and cardiovascular risk method to review which selected trial entry-risk characteristics are present.
Intensive strategy: target SBP <120 mmHg. This is a trial arm description, not an individualized prescription.
Clinical context
SPRINT (Systolic Blood Pressure Intervention Trial) compared an intensive systolic blood-pressure target of <120 mmHg with a standard target of <140 mmHg in selected adults with hypertension and increased cardiovascular risk, without diabetes or a history of stroke.
The original trial reported fewer major cardiovascular events and deaths in the intensive-treatment group, while some serious adverse events were more frequent. The result should not be interpreted as evidence that every patient should be treated to an SBP below 120 mmHg.
Selected increased-risk entry characteristics
| Characteristic | SPRINT criterion |
|---|---|
| Age | Age ≥75 years |
| Chronic kidney disease | eGFR 20 to <60 mL/min/1.73 m², excluding polycystic kidney disease |
| Estimated risk | Framingham 10-year cardiovascular risk ≥15% |
| Cardiovascular disease | Clinical or subclinical cardiovascular disease other than stroke, according to the trial protocol |
Important limits
- This calculator does not assess all SPRINT inclusion or exclusion criteria, including baseline SBP, diabetes, prior stroke, symptomatic heart failure, or other protocol exclusions.
- It does not calculate an individual absolute risk reduction, number needed to treat, or probability of benefit.
- Clinical assessment should include measurement technique, orthostatic symptoms, frailty, comorbidities, kidney function, electrolytes, medication burden, and patient preferences.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.